Clinical trial in Ethiopia targets the trachoma scourge

Trachoma is the leading cause of infectious blindness in the world, with Ethiopia the most impacted country in Africa. In a clinical trial of more than 2,400 individuals, researchers led by Dr. John Kempen of Mass Eye and Ear found a topical anti-inflammatory treatment, fluorometholone, was not effective at reducing postoperative trachomatous trichiasis. Their research is published in The Lancet Global Health.

source https://medicalxpress.com/news/2026-01-clinical-trial-ethiopia-trachoma-scourge.html